INNOCAN PHARMA Corp
Pharmaceutical company · Calgary, Alberta, Canada · OTC: INNPF
INNOCAN PHARMA Corp is a pharmaceutical company headquartered in Calgary, Alberta, Canada. Its earliest recorded incorporation is in 2018. Its shares trade on OTC under the ticker INNPF. It has reported private securities offerings to the US SEC, most recently $6.6 million sold in a notice filed in 2021.
INNOCAN PHARMA at a glance
What does INNOCAN PHARMA do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $6.6 million sold (2021).
Frequently asked questions about INNOCAN PHARMA
Where is INNOCAN PHARMA headquartered?
INNOCAN PHARMA Corp is headquartered in Calgary, Alberta, Canada.
What does INNOCAN PHARMA do?
INNOCAN PHARMA Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is INNOCAN PHARMA a public company?
Yes. INNOCAN PHARMA Corp trades on OTC under the ticker INNPF.
When was INNOCAN PHARMA founded?
The earliest incorporation on record for INNOCAN PHARMA Corp is in 2018, according to public company registers.
Similar companies
- Pacylex Pharmaceuticals Inc.Calgary, Alberta, Canada
- Solaeromed Inc.Calgary, Alberta, Canada
- Aurinia Pharmaceuticals Inc.Edmonton, Alberta, Canada
- AbCellera Biologics Inc.Vancouver, British Columbia, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Satellos Bioscience Inc.Markham, Ontario, Canada
- Edesa Biotech, Inc.Markham, Ontario, Canada
- Eupraxia Pharmaceuticals Inc.Vancouver, British Columbia, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences